Immunotherapies and immunomodulatory approaches in clinical trials - a mini review

• Main Authors: Mohd. Iqbal Yatoo (Author), Zeenat Hamid (Author), Izhar Rather (Author), Qurat Ul Ain Nazir (Author), Riyaz Ahmed Bhat (Author), Abrar Ul Haq (Author), Suhail Nabi Magray (Author), Zulfqar Haq (Author), Ranjit Sah (Author), Ruchi Tiwari (Author), SenthilKumar Natesan (Author), Muhammad Bilal (Author), Harapan Harapan (Author), Kuldeep Dhama (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies involving convalescent plasma, immunoglobulins, antibodies (monocl...